Material and Method: Ninety-nine patients who were admitted to Samsun Training and Research Hospital's Internal Medicine outpatient clinic and satisfied the inclusion criteria were included in this study. Prior to bariatric surgery, preoperative measures were taken, and six months following the procedure, postoperative measurements were taken. Fasting blood glucose, LDL and HDL cholesterol, triglycerides, HbA1c, body-mass index (BMI), fat and fat-free mass, muscle mass, mineral content, protein level, and TGI were evaluated. Appropriate parametric and nonparametric statistical tests were applied according to data distribution.

Results: Comparative analysis revealed statistically significant differences between preoperative and postoperative measurements for all parameters except protein level. The mean TGI decreased from 2.05±0.13 preoperatively to 1.96±0.10 postoperatively. Similarly, the mean BMI decreased from 40.9±8.2 to 29.3±5.7. Significant reductions were also observed in fat mass, muscle mass, and fat-free mass in the postoperative period.

Conclusion: Bariatric surgery significantly improves TGI and body composition parameters in patients with severe obesity, supporting its beneficial effects on metabolic health and insulin resistance. Further long-term studies with larger sample sizes are needed to confirm the durability of these effects.

For patients with severe obesity (BMI ≥40 kg/m2), bariatric surgery is universally acknowledged as the most effective therapeutic option for attaining sustained weight loss. Bariatric surgery has become much more common worldwide in recent years due to its demonstrated effectiveness in improving metabolism and reducing weight⁴. Bariatric surgery has been demonstrated to alleviate or resolve obesity-related comorbidities, such as hypertension, type 2 diabetes mellitus, obstructive sleep apnea, and hyperlipidemia, in addition to causing significant weight loss⁵.

Common bariatric surgical techniques include sleeve gastrectomy, biliopancreatic diversion, vertical banded gastroplasty, jejunoileal bypass, laparoscopic adjustable gastric banding, duodenal switch, and Roux-en-Y gastric bypass⁶. Sleeve gastrectomy has gained popularity due to its relative technical simplicity and favorable short- and mid-term outcomes; however, long-term data remain limited, and as a restrictive procedure, it carries a risk of protein malnutrition⁷. In contrast, extensive data are available on the long-term metabolic effects of Roux-en-Y gastric bypass, which combines gastric restriction with intestinal malabsorption⁸.

The gold standard for determining insulin resistance is the hyperinsulinemic–euglycemic clamp technique⁹. However, because of its high cost, technical complexity, and time constraints, its routine clinical application is restricted¹⁰. Insulin resistance is pathophysiologically based on long-term increases in plasma glucose and lipid levels. In this regard, the triglyceride–glucose index (TGI), which shows a substantial connection with insulin resistance as determined by the hyperinsulinemic–euglycemic clamp technique, has become a straightforward and trustworthy surrogate marker¹¹. The following formula is used to determine TGI:

TGI readings above 4.69 are typically regarded as suggestive of insulin resistance, despite the fact that different cutoff values have been suggested¹². Anthropometry is the study of human body composition by measuring elements including bone tissue, muscle mass, fat mass, and lean mass¹³. These measure-ments offer important insights into the distribution of adipose tissue, protein content, and general nutritional health. Anthropometric measurements are frequently employed in nutritional monitoring, growth assessment, and the assessment of obesity in a variety of age groups¹⁴. Body composition analysis relies heavily on parameters like lean body mass, height, and body weight¹⁵.

In this context, the present study aimed to comparatively evaluate preoperative and postoperative triglyceride-glucose index values and body composition parameters in patients undergoing bariatric surgery.

Postoperative analyses demonstrated significant reductions in anthropometric and body composition parameters. The mean body mass index (BMI) decreased from 40.9 ± 8.2 kg/m² preoperatively to 29.3 ± 5.7 kg/m² postoperatively (p <0.001). Fat-free mass was reduced from 60.9 ± 12.3 kg to 53.7 ± 11.3 kg (p <0.001), and mineral content decreased from 3.9 ± 1.0 kg to 3.4 ± 0.8 kg (p <0.001). Protein content showed a slight, non-significant reduction from 11.7 ± 2.4 kg to 11.4 ± 2.1 kg (p =0.102). Muscle mass decreased from a median of 54 kg (range: 37-92 kg) to 50.2 ± 10.3 kg (p <0.001), while fat mass decreased markedly from a median of 46 kg (range: 16-94 kg) to 23 kg (range: 7-50 kg) (p <0.001), reflecting substantial postoperative improvements in body composition. BMI, Fat-free mass, muscle mass and fat mass, and mineral content and protein content parameters for all participants are summarized in figure 1 and 2.

Click Here to Zoom

Figure 1: Changes in body mass index (BMI), fat-free mass, muscle mass and fat mass before and six months after bariatric surgery in all study participants. a: pre-op group vs post-op group (p <0.001).

Click Here to Zoom

Figure 2: Changes in mineral and protein content before and six months after bariatric surgery in all study participants. a: pre-op group vs post-op group (p <0.001).

Postoperative analyses revealed significant improvements in all metabolic parameters. Fasting blood glucose decreased from 113.4 ± 32.6 mg/dL preoperatively to 95.7 ± 18.7 mg/dL postoperatively (p <0.001). LDL-cholesterol levels were reduced from 130.5 ± 41.9 mg/dL to 105.1 ± 27.3 mg/dL (p <0.001), whereas HDL-cholesterol increased significantly from 45.4 ± 14.5 mg/dL to 52.1 ± 11.1 mg/dL (p <0.001). Triglyceride levels decreased from a median of 109 mg/dL (range: 37-313 mg/dL) to 88 mg/dL (range: 37-274 mg/dL) (p <0.001, Figure 3), and HbA1c levels declined from 5.6 ± 1.2% to 5.0 ± 0.8% (p <0.001). Consistently, the triglyceride–glucose index (TGI) decreased from 2.05 ± 0.13 preoperatively to 1.96 ± 0.10 postoperatively (p <0.001), indicating a marked improvement in insulin sensitivity following bariatric surgery (Figure 4).

Click Here to Zoom

Figure 3: Changes in fasting blood glucose, triglycerides, LDL-cholesterol, and HDL-cholesterol before and six months after bariatric surgery. a: pre-op group vs post-op group (p <0.001).

Click Here to Zoom

Figure 4: Changes in HbA1c and triglyceride-glucose index (TGI) before and six months after bariatric surgery. a: pre-op group vs post-op group (p <0.001).

Significant decreases in body composition measures were noted concurrently. BMI dropped from 40.9 ± 8.2 to 29.3 ± 5.7 kg/m² (p <0.001), fat mass significantly decreased, and muscle and fat-free mass also fell, but to a lesser degree. Protein content did not alter statistically, indicating that vital metabolic processes were maintained. These results are consistent with earlier research demonstrating that, especially in the early postoperative phase, bariatric surgery largely targets fat tissue while reducing lean mass loss^24,25. A more thorough evaluation of the quality and metabolic significance of postoperative weight reduction can be obtained by tracking body composition rather than depending just on the proportion of excess weight loss^26,27.

When considered collectively, these findings show that bariatric surgery successfully promotes positive changes in body composition while improving insulin resistance and general metabolic health. The procedure's clinical usefulness in the treatment of morbid obesity is highlighted by the fact that it not only promotes significant weight loss but also maintains lean mass and improves metabolic function. Long-term studies with bigger cohorts are necessary to corroborate these findings and assess the sustainability of metabolic and body composition changes because the study's primary limitations are its relatively small sample size and short follow-up duration of six months.

Conflict of interest
The authors declare that there is no conflict of interest.

Financial support
The authors do not declare any financial support.

Ethical Approval
This study received ethical approval from the Samsun University Clinical Research Ethics Committee with decision number SÜKAEK 2023 20/7 dated 01.11.2023.

1) Batar N. Bariatrik Cerrahide Beslenme İlkeleri. Med J Bakirkoy 2019; 15: 323-32.

2) Balcı H, Küçükkendirci H. Obezite Ve Obezite Cerrahisinde Beslenme. Türk Bilimsel Derlemeler Dergisi. 2019; 12: 45-50.

3) Aydın E, Bulut H. Bariatrik Cerrahide Hemşirelik Bakımı. TAF Preventive Medicine Bulletin 2014; 13: 77-82.

4) El Ansari W, Elhag W. Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review. Obes Surg 2021; 31: 1755-66.

5) Ünal Ş, Sevinçer GM, Maner AF. Bariatrik cerrahi sonrası kilo geri alımının; gece yeme, duygusal yeme, yeme endişesi, depresyon ve demografik özellikler tarafından yordanması. Türk Psikiyatri Dergisi 2019; 30: 31-41.

6) Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 14: 160-9.

7) Peterli R, Wolnerhanssen BK, Bueter M. Response to: "Are Guidelines for Standardized Outcome Reporting in Bariatric Surgery Responsible for Missing the Big Picture in Bariatric Surgery Related Major Complications?". Ann Surg 2018; 268: e13-4.

8) Topuz C, Baturay F, Çakırgöz M, Ersoy A. Morbid obezite cerrahisi ve anestezi. Okmeydanı Tıp Dergisi 2014; 30: 56-9.

9) DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.

10) Morris AD, Ueda S, Petrie JR, Connell JM, Elliott HL, Donnelly R. The euglycaemic hyperinsulinaemic clamp: an evaluation of current methodology. Clin Exp Pharmacol Physiol 1997; 24: 513-8.

11) Lee SH, Kwon HS, Park YM et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One 2014; 9: e90430.

12) Pranata R, Huang I, Irvan, Lim MA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose–response meta-analysis of cohort studies. Endocrine 2021; 74: 254-62.

13) Preedy VR. Handbook of anthropometry: physical measures of human form in health and disease: Springer Science & Business Media 2012.

14) McDowell MA, Fryar CD, Ogden CL. Anthropometric reference data for children and adults: United States, 1988-1994. 2009. Report No.: 0083-1980 Contract No.: 249.

15) Baysal A, Aksoy M, Besler H et al. Diyet el kitabı. Ankara: Hatipoğlu Baskı 2002; 225-53 p.

16) Cheraghpour M, Alipour M, Tabesh MR, Asadzadeh-Aghdaei H, Zahedi H, Nazari M, et al. Effects Gastric Bypass vs. Sleeve Gastrectomy on Lipid Indices in Obese Adults: A Retrospective Cohort. J Nutrition Fasting & Health 2022;10.

17) Luo P, Cao Y, Li P, Wang G, Song Z, Li W, et al. Insulin Resistance Remission Following Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Chinese Type 2 Diabetes Mellitus Patients With a Body Mass Index of 27.5-32.5 kg/m(2). Front Physiol 2021; 12: 772577.

18) Shadnoush M, Rajabian Tabesh M, Asadzadeh-Aghdaei H, Hafizi N, Alipour M, Zahedi H, et al. Effect of bariatric surgery on atherogenicity and insulin resistance in patients with obesity class II: a prospective study. BMJ Open 2023; 13: e072418.

19) Brzozowska MM, Isaacs M, Bliuc D, Baldock PA, Eisman JA, White CP, et al. Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period. Sci Rep 2023; 13: 6032.

20) Salehi M, D’Alessio DA. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe. Surgery Obesity Related Dis 2016; 12: 1230-5.

21) Juarez-Fernandez M, Roman-Saguillo S, Porras D, Garcia-Mediavilla MV, Linares P, Ballesteros-Pomar MD, et al. Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission. Nutrients 2021; 13: 8.

22) Liu H, Hu C, Zhang X, Jia W. Role of gut microbiota, bile acids and their cross‐talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabet Invest 2018; 9: 13-20.

23) Ryan KK, Tremaroli V, Clemmensen C et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509: 183-8.

24) Nicoletti CF, Camelo Jr JS, dos Santos JE, Marchini JS, Salgado Jr W, Nonino CB. Bioelectrical impedance vector analysis in obese women before and after bariatric surgery: changes in body composition. Nutrition 2014; 30: 569-74.

25) Sherf-Dagan S, Zelber-Sagi S, Buch A et al. Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy. Obes Surg 2019; 29: 3833-41.

26) Azagury D, Mokhtari TE, Garcia L et al. Heterogeneity of weight loss after gastric bypass, sleeve gastrectomy, and adjustable gastric banding. Surgery 2019; 165: 565-70.

27) Faria SL, Faria OP, Cardeal MD, Ito MK. Validation study of multi-frequency bioelectrical impedance with dual-energy X-ray absorptiometry among obese patients. Obesity Surgery 2014; 24: 1476-80.